AqVida Signs Agreement for Technology Transfer

Press Release – AqVida GmbH
AqVida Signs Agreement for Technology Transfer

AqVida Logo

Contact Supplier: AqVida GmbH
Supplier Press Release: AqVida Signs Agreement for Technology Transfer
Address: Kaiser-Wilhelm-Str.89, 20355 Hamburg, Germany
Tel: +49 40 380 37190
Fax: +49 40 380 37192
Website: www.aqvida.com

MAY 08, 2013

AqVida Signs Agreement for Technology Transfer

German pharmaceutical company, AqVida, has announced it has entered into an agreement to collaborate with Tunisia-based Cytopharma in the completion of a plant for oncology injectables.

AqVida will offer its experience in the field of oncology product production. AqVida’s knowledge of the European market requirements will also be used and will ensure that from the outset all processes will comply with EU-GMP.

For this collaboration, the company is delighted to be able to backward integrate from development, registration and licensing to supporting the building of production capacities. Wolfgang Heinze, CEO of AqVida commented that choosing the right partner for such a long-term project depended upon meeting specific criteria. The company understands having a base in Tunisia will allow them to tap into the already high level of pharmaceutical and engineering know-how, plus the synergy between AqVida and Cytopharma will help ensure this is a successful collaboration.

This strategic investment will see the Hamburg-based company register its first products as early as mid 2014.

About AqVida
AqVida specializes in the development, registration and supply of generic oncology products and biosimilars to become a leading partner in the pharmaceutical industry. The company is based in Hamburg, Bavaria and Hangzhou China.

AqVida works alongside some of the major companies in the market of oncology products. Together with its partners AqVida has achieved substantial development and growth with its oncology portfolio.

As a pharmaceutical company AqVida fulfills all your requirements from API sourcing up to EU market release for the finished product. A team of experts in development, regulatory affairs, patent issues and laboratory work closely together to achieve the best results for customers.

Products are offered under the AqVida brand or under partners’ brands in the EU and less regulated markets.

AqVida complies with all German and EU legal requirements for the pharmaceutical industry including, EU-GMP, AMG and AMWHV and is also GMP certified by the German Health Authorities. As a European organisation AqVida understands the vast and highly regulated European market and has the knowledge and resources to provide regulatory support. They are also able to assist manufacturers outside the EU to help them enter the European market.

For more information or to discuss AqVida signs agreement for technology transfer please contact AqVida directly.

Comments are closed.